The germline markers, stage-specific embryonic antigen (SSEA-1), c-KIT and VASA can be used as a complementary tool to create new molecular categories for diagnoses in azoospermic patients, which may be particularly useful to discriminate between mosaic and non-mosaic SCOS patients [29]. Here, DDX4 is linked to small cell osteogenic sarcoma.